What is the recommended dosage of Ondansetron (Ondansetron HCl) for a 6-year-old patient weighing approximately 20 kg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ondansetron Dosing for a 6-Year-Old Child

For a 6-year-old child weighing approximately 20 kg, administer ondansetron 0.15 mg/kg, which equals 3 mg per dose, with an absolute maximum single dose of 16 mg. 1, 2

Weight-Based Dosing Calculation

  • The standard pediatric dose is 0.15 mg/kg per administration 1, 2, 3
  • For a 20 kg child: 0.15 mg/kg × 20 kg = 3 mg per dose 2
  • This dosing applies regardless of route (IV, IM, or oral) 2, 3

Route-Specific Administration

Intravenous (IV) Administration

  • Administer 3 mg (0.15 mg/kg) IV over 2-5 minutes 3
  • Maximum single dose: 16 mg 1, 2, 3

Intramuscular (IM) Administration

  • Use the same dose as IV: 3 mg (0.15 mg/kg) IM when IV access is difficult 2, 3
  • IM route is an acceptable alternative with equivalent dosing 2, 3

Oral Administration

  • Oral dosing follows the same 0.15 mg/kg calculation = 3 mg 4
  • Oral bioavailability is 59%, but the recommended dose remains unchanged 5, 6

Clinical Context and Frequency

For Postoperative Nausea/Vomiting

  • Single dose of 0.15 mg/kg (3 mg) is typically sufficient 3

For Chemotherapy-Induced Nausea/Vomiting

  • Administer 0.15 mg/kg every 4 hours for three doses (30 minutes before chemotherapy, then at 4 and 8 hours) 3, 5
  • Consider adding dexamethasone for enhanced efficacy, as combination therapy significantly improves antiemetic control compared to ondansetron alone 1, 3, 4

For Acute Gastroenteritis

  • Single oral dose of 0.1-0.15 mg/kg (2-3 mg) effectively reduces vomiting 7
  • One dose decreased continued vomiting from 42.9% to 19.5% within 4 hours 7

Critical Safety Considerations

  • Exercise special caution in children with cardiac disease or known heart conditions due to potential QT interval prolongation 1, 2, 3
  • Monitor for cardiac effects if the child has any underlying heart disease 2
  • Ondansetron is generally well tolerated in pediatric patients, with headache, constipation, and diarrhea being the most common mild adverse events 4

Common Pitfalls to Avoid

  • Never exceed 16 mg as a single dose, regardless of calculated weight-based dosing 1, 2, 3
  • Do not confuse the 0.15 mg/kg pediatric dose with adult fixed dosing regimens 8
  • Pediatric patients have increased clearance (half-life 2.5 hours) compared to adults, but this does not require dose adjustment beyond standard weight-based calculation 6
  • The 32 mg single-dose regimen mentioned in some adult guidelines should not be extrapolated to pediatric patients 5

References

Guideline

Ondansetron and Dicyclomine Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Ondansetron Dosing Guidelines for Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Ondansetron IV Dosage for Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Ondansetron: a novel antiemetic agent.

Southern medical journal, 1993

Research

Ondansetron metabolism and pharmacokinetics.

Seminars in oncology, 1992

Research

Oral ondansetron for paediatric gastroenteritis in primary care: a randomised controlled trial.

The British journal of general practice : the journal of the Royal College of General Practitioners, 2021

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.